InterCure Ltd. (NASDAQ:INCR) Q1 2022 Earnings Conference Call May 17, 2022 8:00 AM ET

Company Participants

Adam Haliva - Communications Officer

Alex Rabinovitch - Chief Executive Officer

Amos Cohen - Chief Financial Officer

Conference Call Participants

Matt Bottomley - Canaccord

Operator

Hello, thank you for standing-by and welcome to the InterCure First Quarter 2022 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference maybe recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Adam Haliva, Communications Officer at InterCure. Please, go ahead.

Adam Haliva

Thank you, Josh. Good morning, everybody and welcome to InterCure’s first quarter 2022 results conference call and webcast. A copy of the company's earnings press release is available on the News & Events section of our website at www.intercure.co.

With me on today's call are Alex Rabinovitch, InterCure’s Chief Executive Officer; and Amos Cohen, the company's Chief Financial Officer. Today, we'll review the highlights and financial results for the first quarter ended March 31, 2022, as well as more recent developments. Following these formal remarks, we will be prepared to answer your questions.

Before we begin, please let me remind you that during this conference call InterCure’s management may make forward-looking statements made within the meaning of applicable security laws. Forward-looking statements may include, but are not necessarily limited to, financial projections or other statements of the company's plans, objectives, expectations or intentions.

These forward-looking statements are based on current expectations that are subject to a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied in such statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors contained in the company's filings with SEDAR and the Securities and Exchange Commission.

Please also note, any forward-looking statements made here are as of today, and except to the extent required by law. The company assumes no obligation to update statements as circumstances change. Also, please note that all amounts expressed during this call are in Canadian dollars or new Israeli shekels, unless otherwise noted.

Now, I will turn the call over to Alex Rabinovitch, InterCure’s CEO. Alex, go ahead please.

Alex Rabinovitch

Thank you, Adam, Good afternoon everyone and thank you for joining us for the first quarter 2022 earnings call. I’m proud to report a great start to 2022 with strong first quarter results demonstrated by total growth, continued positive cash flow from operations, positive adjusted EBITDA, and continued progress in scaling our operation across all segments. We continue to successfully execute what we have stated, providing the highest quality from critical branded cannabis products, while delivering profitable growth.